AzTrials
AzTrials

Lifestyle, HealthyRESTARTNCT06122441

RE-inventing Strategies for Healthy Ageing; Recommendations and Tools

A study testing Complex lifestyle intervention and Physical activity monitoring and recommendations in people with Lifestyle, Healthy and Muscle Weakness, run by University of Tromso at 1 site in Norway.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of the RESTART RCT is to examine whether a complex lifestyle intervention, coordinated with municipal and non-government organizations (NGO), can establish and preserve improvements in risk factors and functional capacity among older adults at high risk of cardiometabolic disease. Read more about this study

Who is it for?
Ages 60 to 75 years
What is being tested?
Complex lifestyle intervention and Physical activity monitoring and recommendations
Could I receive a placebo?
No, everyone receives an active treatment
How many people
119 participants
Where
1 siteNorway
Study dates
15 Jan 2024to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 60-75 years
  • BMI ≥ 30 kg/m2
  • Elevated CVD-risk (Score 8/12 on the NORRISK 2 model)
  • Sedentary lifestyle (Score "1" on the Saltin-Grimby Physical Activity Level Scale)

Who cannot join

  • Presence of dementia diagnosis
  • Self-reported previous myocardial infarction or stroke, and/or self-reported established cardiovascular disease by presence of coronary stent
  • Heart failure with ejection fraction <50%
  • Electrocardiogram ECG presenting with atrioventricular block grade 2 type 2 or grade 3, or previous myocardial infarction.
  • Uncontrolled hypertension (systolic blood pressure≥180 mmHg and/or diastolic blood pressure≥110 mmHg unless cleared by a nephrologist)
  • Chronic obstructive pulmonary disease grade 3 or 4
Show all 16Show fewer
  • Thyroid dysfunction (thyroxine <7 pmol/L and thyroid-stimulating hormone >10 mIU/L, and/or thyroxine >25 pmol/L and thyroid-stimulating hormone <0.2 mIU/L)
  • Liver dysfunction (alanine aminotransferase >210 µmol/L for men, >135 µmol/L for women, and/or aspartate aminotransferase >135 µmol/L for men, >105 µmol/L for women, and/or alkaline phosphatase >345 µmol/L)
  • Kidney dysfunction (creatinine >220 µmol/L), in addition to prognosis of CKD by GFR and Albuminuria KDIGO 2012 algorithm
  • Severe anemia (hemoglobin <10g/dL for men, <8g/dL for women)
  • Uncontrolled diabetes (glycated hemoglobin ≥86 mmol/mol)
  • Severe hearing problems
  • Severe mobility limitations (unable to get up from a sitting or lying position, unable to maintain a crouched position, unable to raise arms above shoulder or head height)
  • No possession of a smartphone
  • No access to the Norwegian national identification service (BankID)
  • Unable to follow the trial regimen for 24 months

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • UiT The Arctic University of Norway

    Tromsø, Troms, 9018

Other trials in Norway

About this study

Official title: RE-inventing Strategies for Healthy Ageing; Recommendations and Tools (RESTART) - a Randomized Controlled Trial Testing a Complex Lifestyle Intervention in Older Adults at Increased Risk for Cardiometabolic Disease

The goal of the RESTART RCT is to examine whether a complex lifestyle intervention, coordinated with municipal and non-government organizations (NGO), can establish and preserve improvements in risk factors and functional capacity among older adults at high risk of cardiometabolic disease. The main objectives to investigate are whether a complex lifestyle intervention, compared to an active control group, will at 24 months have:

  1. Produced a clinically relevant increase in cardiorespiratory fitness (primary endpoint)
  2. Increased muscle strength, physical activity and reduced adiposity
  3. Improved body composition, health-related quality of life and cognitive function

All participants (Control and Intervention Groups) are provided with wrist-worn activity trackers at baseline and access to national recommendations on physical activity. The intervention group additionally advances through a comprehensive lifestyle program including high-intensity aerobic and strength exercise, dietary and behavioral counselling. Intervention participants are gradually transitioned into exercise activities organized by Tromsø Municipaity and local NGO:s. Testing of outcomes are performed at baseline, 6, 12 and 24 months. Primary endpoint (VO2max) is assessed at 24 months.

Read the detailed description

The proportion of older individuals worldwide is growing, posing a significant challenge to western societies. To address the health challenges of the aging population, primary prevention efforts should focus on various lifestyle factors simultaneously. However, many interventions fail to maintain improved lifestyle habits among participants, highlighting the need for novel and complex approaches to ensure healthy aging among older adults.

The RESTART randomized controlled trial aims to investigate whether participants undergoing a complex lifestyle intervention improve their cardiorespiratory fitness, muscle strength, physical activity, adiposity and body composition, quality of life and cognitive function at 24 months, compared to active controls.

The study and data collection will occur in Tromsø, Norway (pop. 77,000). Participants will receive the intervention at a local community exercise center near the University of Tromsø campus area. Testing of physical performance will take place at the UiT Faculty of Health Sciences research laboratory for sports, physical activity, and public health. The Clinical Trial Unit (CTU) at the local university hospital will additionally oversee clinical examinations, collection of questionnaire data, and blood sampling.

At baseline, both the Control and Intervention Groups are given wrist-worn activity trackers and access to national physical activity recommendations. The Intervention Group also undergoes a comprehensive lifestyle program that includes high-intensity aerobic and strength exercises, as well as dietary and behavioral counseling. The Intervention Group is gradually introduced to exercise activities organized by Tromsø Municipality and local NGOs. Outcome testing is conducted at baseline, 6, 12, and 24 months, with the primary endpoint (VO2max) assessed at 24 months.

Intervention participants will be divided into 4 groups of 12-15 participants each and perform high-intensity training to target the cardiovascular system and skeletal muscle force-generating capacity. For 12 months, the intervention group performs supervised indoor cycling or outdoor hill interval training twice a week at a relatively high intensity (≥85% of maximal heart rate during 4x4 minutes) separated by active rest periods at approximately 70% of maximal heart rate. Immediately after the aerobic exercise, participants perform strength training (3 sets of 5 repetitions) involving leg-press, lateral pull-down, and chest press exercises, with an intensity corresponding to ≥80% of their maximal strength. From months 6-12, one of the two weekly exercise sessions will be led by the Healthy Life Center (HLC; "Frisklivssentralen"), enabling a transition to supervised exercise via the Tromsø municipality primary health care. Between month 12-18, the HLC continue to supervise the participants during one weekly exercise sessions, while they are additionally introduced to exercise activities arranged by local NGO:s.

From month 3 to 12, participants will receive behavioral counseling based on the Acceptance and Commitment Therapy (ACT) approach during six 2-hour group sessions. The individual approach aims to enhance participants' capacity to manage challenging cognitive and emotional experiences, foster psychological flexibility and distress tolerance skills, and promote the development of self-efficacy and new behavior patterns that align with their life values.

From month 6 to 12, the intervention group will receive four dietary counseling sessions based on Norwegian nutritional guidelines. Two individual sessions will involve food diaries, while two group sessions with a partner will focus on basic nutritional information and practical food preparation. The objective is to promote a healthy, sustainable, and personalized diet while promoting increased protein intake, reducing the consumption of high-energy-dense foods and drinks with low nutritional value.

Beginning from month 12 and onwards throughout the trial, the intervention group will be granted access to the Re-start eTool (https://re-start.no/), which is specifically tailored to older adults. The eTool offers concise and easy-to-understand articles, videos, and self-assessment tools that promote physical activity, healthy dietary habits, and behavioral strategies from the complex intervention. The Re-start eTool aims to provide support and reminders to participants as they gradually transition to independently maintaining the achieved lifestyle habits and physical capacity levels.

Throughout the study period, the intervention instructors and assessors monitor potential adverse events during the exercise and testing phases, and all adverse events are reported to the study coordinator. Measures to mitigate adverse events include: 1) insurance of participants via The Norwegian System of Patient Injury Compensation; 2) involving a MD with sports medicine specialization to ensure treatment of potential injuries; 3) pilot study experiences show that short-term alternative exercises are effective in managing exercise-induced pain and discomfort.

Being tested
Complex lifestyle intervention, Physical activity monitoring and recommendations
Keywords
Complex lifestyle intervention, Older adults, Cardiometabolic risk factors, Cardiorespiratory fitness, Muscle strength, Physical activity, Abdominal obesity, Acceptance and commitment therapy, Health-related quality of life, Cognitive function
Medical subject headings
Muscle Weakness, Obesity, Abdominal, Metabolic Syndrome, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Complex lifestyle interventionBehavioural

    The complex lifestyle intervention comprise high-intensity aerobic and strength exercise, behavioral counselling based on Acceptance and Commitment Theory (ACT), and dietary counselling based on Norwegian nutritional guidelines. The different intervention elements are introduced step-wise to reduce initial overload. Participants are progressively transitioned over to the Tromsø municipality and local NGO's, who delivers activities harmonized with the intervention elements. Participants are at this stage also supported by an eTool which digitally reinforces the intervention through web-based information and videos.

  • Physical activity monitoring and recommendationsBehavioural

    Wrist-worn activity trackers that are worn throughout the trial, which monitors steps, activity intensity and energy expenditure. Access to Norwegian physical activity guidelines via the Directorate of Health.

Study groups in NCT06122441
Study groupRoleWhat they receive
Complex lifestyle interventionExperimentalReceives a complex lifestyle intervention, a wrist-worn activity tracker, and access to national recommendations on physical activity.
Receives: Behavioral: Complex lifestyle intervention; Behavioral: Physical activity monitoring and recommendations
Active controlActive comparatorReceives a wrist-worn activity tracker and access to national recommendations on physical activity.
Receives: Behavioral: Physical activity monitoring and recommendations

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in VO2max at month 24

    Assessed as ml/kg/min during an incremental test-to-exhaustion where the participant walks or runs on a motorized treadmill.

    Measured: Baseline and month 24

  2. Change from baseline in VO2max at month 12

    Assessed as ml/kg/min during an incremental test-to-exhaustion where the participant walks or runs on a motorized treadmill.

    Measured: Baseline and month 12

  3. Change from baseline in VO2max at month 6

    Assessed as ml/kg/min during an incremental test-to-exhaustion where the participant walks or runs on a motorized treadmill.

    Measured: Baseline and month 6

Secondary outcomes (16)
  1. Change from baseline in muscle strength at month 24

    Assessed as the highest kg achieved during a 1-repetition maximum test in leg-press and chest-press apparatuses.

    Measured: Baseline and month 24

  2. Change from baseline in muscle strength at month 12

    Assessed as the highest kg achieved during a 1-repetition maximum test in leg-press and chest-press apparatuses.

    Measured: Baseline and month 12

  3. Change from baseline in muscle strength at month 6

    Assessed as the highest kg achieved during a 1-repetition maximum test in leg-press and chest-press apparatuses.

    Measured: Baseline and month 6

  4. Change from baseline in muscle power at month 24

    Assessed as power (W; force x speed of contraction) during leg-press exercise with pre-defined weight ascertained during baseline measurements

    Measured: Baseline and month 24

  5. Change from baseline in muscle power at month 12

    Assessed as power (W; force x speed of contraction) during leg-press exercise with pre-defined weight ascertained during baseline measurements

    Measured: Baseline and month 12

  6. Change from baseline in muscle power at month 6

    Assessed as power (W; force x speed of contraction) during leg-press exercise with pre-defined weight ascertained during baseline measurements

    Measured: Baseline and month 6

  7. Change from baseline in waist circumference at month 24

    Assessed in centimeters at the umbilical level (between crista iliaca and the lower rib) using a measurement tape.

    Measured: Baseline and month 24

  8. Change from baseline in waist circumference at month 12

    Assessed in centimeters at the umbilical level (between crista iliaca and the lower rib) using a measurement tape.

    Measured: Baseline and month 12

  9. Change from baseline in waist circumference at month 6

    Assessed in centimeters at the umbilical level (between crista iliaca and the lower rib) using a measurement tape.

    Measured: Baseline and month 6

  10. Change from baseline in body weight at month 24

    Assessed in kilograms using a SECA personal weight. Participants are measured without outdoor clothing and shoes.

    Measured: Baseline and month 24

  11. Change from baseline in body weight at month 12

    Assessed in kilograms using a SECA personal weight. Participants are measured without outdoor clothing and shoes.

    Measured: Baseline and month 12

  12. Change from baseline in body weight at month 6

    Assessed in kilograms using a SECA personal weight. Participants are measured without outdoor clothing and shoes.

    Measured: Baseline and month 6

  13. Change from baseline in minutes in moderate-to-vigorous physical activity per day at month 24

    Assessed as minutes in light, moderate and vigorous intensity, using triaxial accelerometers worn at the hip for 7 days.

    Measured: Baseline and month 24

  14. Change from baseline in minutes in moderate-to-vigorous physical activity per day at month 12

    Assessed as minutes in light, moderate and vigorous intensity, using triaxial accelerometers worn at the hip for 7 days.

    Measured: Baseline and month 12

  15. Change from baseline in minutes in moderate-to-vigorous physical activity per day at month 6

    Assessed as minutes in light, moderate and vigorous intensity, using triaxial accelerometers worn at the hip for 7 days.

    Measured: Baseline and month 6

  16. Daily physical activity pattern

    Asessed using wrist-worn smartwatches that are worn by the participants continously and measures steps, activity intensity and energy expenditure

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Nov 2023
  2. Study start15 Jan 2024
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
RESTART is designed as a two-arm, single blind, parallel group RCT, with a 1:1 allocation ratio into either intervention or active control group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
119 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06122441
Sponsor's protocol ID
2023/584841(REK)
Other IDs
2023
Acronym
RESTART
Status last verified
Apr 2026
First submitted
26 Oct 2023
Last updated
29 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The principal investigators will have access to the final, complete trial dataset. Other investigators can apply to the steering committee for data and may receive access to data with variables specific to the research question of interest.

Publications

  • Johansson J, Deraas TS, Hopstock LA, Henriksen A, Grimsgaard S. Improving and preserving cardiorespiratory fitness, muscle strength and adiposity through a complex lifestyle intervention in community-dwelling older adults with elevated cardiometabolic risk: study protocol for the RESTART randomised controlled trial. BMJ Open. 2025 Apr 19;15(4):e095810. doi: 10.1136/bmjopen-2024-095810.

    PubMed 40254301

Questions about this trial

What is this clinical trial studying?

A study testing Complex lifestyle intervention and Physical activity monitoring and recommendations in people with Lifestyle, Healthy and Muscle Weakness, run by University of Tromso at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in VO2max at month 24 (time frame: Baseline and month 24). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06122441, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in